Abstract

Abstract The relative contributions of CD4 vs. CD8 T cell subsets in graft-versus-host disease (GVHD) remains poorly defined. Previous studies in this lab have shown that the integrin CD103 is required for accumulation of CD8 T cells in epithelial compartments and concomitant epithelial injury during GVHD in MHC-mismatched transplant models. The goal of the present study was to define the role of the CD103 pathway in promoting GVHD following MHC-matched BMT, the most common clinical scenario. Our data showed no difference in the ability of WT or CD103-/- splenocytes to cause acute GVHD mortality in this transplant scenario. However, depletion of CD4 T cells on day 6 post transplant completely prevented acute GVHD mortality, despite a robust CD8 T cell response. These data suggested that acute gut injury and mortality elicited following BMT are mediated by CD4 T cells rather than CD8 T cells as is commonly assumed. Consistent with this hypothesis, CD4 depletion also prevented acute mortality following MHC-mismatched transplant. FACS analyses of long-surviving hosts in this model revealed that T cells infiltrating the host gut epithelium were initially CD103- but progressively acquired CD103 expression concomitant with progressive epithelial injury. These data indicate that CD103 is preferentially expressed by CD8 T cells at late post-transplant intervals, and that effective blockade of GVHD pathology will likely require combined blockade of the CD4 and CD103 pathways.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call